Study of Ultrasonographic Cava Femoral Ratio in the Critically Ill Patient With Shock
ECHO-RCF
1 other identifier
observational
100
1 country
1
Brief Summary
This study aims to describe the ratio of the diameter of inferior vena cava to the common femoral vein measured by ultrasonography in critically ill patients with shock, and to evaluate the potential link between this ratio and the existence of intra-abdominal disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 11, 2016
CompletedFirst Posted
Study publicly available on registry
September 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedSeptember 7, 2016
September 1, 2016
1.4 years
August 11, 2016
September 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ratio of the diameter of the inferior vena cava related to the common femoral vein
Up to 28 days after ICU admission
Interventions
At the time of ICU admission, among critically ill patients with shock, the investigators will measure the diameter of the common femoral vein and that of the inferior vena cava by ultrasonography.
Eligibility Criteria
Critically ill patients receiving catecholamine for shock state at the time of ICU admission.
You may qualify if:
- Adult
- Need for ICU admission
- Need for vasopressor (epinephrine or norepinephrine) to obtain a mean arterial pressure at least of 65 mmHg
You may not qualify if:
- Deep venous thrombosis related to inferior vena cava or common femoral veins
- Inability to measure inferior vena cava and common femoral vein diameters using ultrasonography
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Universitaire de Besançon
Besançon, 25030, France
Biospecimen
Analysis of plasma creatinine, aspartate aminotransferase, and arterial blood gases.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gaël PITON, MD, PhD
CHU Besançon
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2016
First Posted
September 7, 2016
Study Start
March 1, 2016
Primary Completion
August 1, 2017
Study Completion
September 1, 2017
Last Updated
September 7, 2016
Record last verified: 2016-09
Data Sharing
- IPD Sharing
- Will not share